APA

Koscielniak E., Klingebiel T. H., Peters C., Hermann J., Burdach S. T., Bender-Götze C., Müller-Weihrich S. T. & Treuner J. (19970429). Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. : Bone marrow transplantation.

Chicago

Koscielniak E, Klingebiel T H, Peters C, Hermann J, Burdach S T, Bender-Götze C, Müller-Weihrich S T and Treuner J. 19970429. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. : Bone marrow transplantation.

Harvard

Koscielniak E., Klingebiel T. H., Peters C., Hermann J., Burdach S. T., Bender-Götze C., Müller-Weihrich S. T. and Treuner J. (19970429). Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. : Bone marrow transplantation.

MLA

Koscielniak E, Klingebiel T H, Peters C, Hermann J, Burdach S T, Bender-Götze C, Müller-Weihrich S T and Treuner J. Do patients with metastatic and recurrent rhabdomyosarcoma benefit from high-dose therapy with hematopoietic rescue? Report of the German/Austrian Pediatric Bone Marrow Transplantation Group. : Bone marrow transplantation. 19970429.